单位：[1]Department of Respiratory and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.[2]Pulmonary Disease Department of Traditional Chinese Medicine, Respiratory Disease Center, China-Japan Friendship Hospital, National Center for Clinical Respiratory Diseases, Beijing 100029, China.[3]Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University, Basic Research on Infectious Diseases of Traditional Chinese Medicine Beijing Key Laboratory, Beijing 100010, China.[4]Chinese Critical Care Medicine Magazine, Tianjin 300050, China. Corresponding author: Song Yuanlin, Email: ylsong70@163.com.
Severe community acquired pneumonia (SCAP) has raised substantial concern due to high morbidity and mortality. SCAP is usually associated with multiple organ dysfunction syndrome (MODS) and sepsis. It is suggested that organ function and coagulation/fibrinolysis improvement, organ injury reduction and organ repair facilitation are highly required besides microbiology detection and optimization of antibiotics strategy on treatment of SCAP. Neutralization antibody, steroid, immunmodulatory therapy, and Chinese medicine etc. contribute to organ function improvement from different perspective. The unique profile of multiple target and personalized therapy of Chinese medicine may become a promising new option for SCAP and MODS. The combination of Western and Chinese Medicine shed new light on SCAP treatment.
语种：
中文
PubmedID：
第一作者：
第一作者单位：[1]Department of Respiratory and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
推荐引用方式(GB/T 7714)：
Song Yuanlin,Zhang Hongchun,Liu Qingquan,等.Current status and prospect of treatment for severe community acquired pneumonia[J].Chinese Critical Care Medicine.2019,31(6):665-668.
